Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Prins, Manon L MRoozen, Geert V T
Pothast, Cilia R
Huisman, Wesley
van Binnendijk, Rob
den Hartog, Gerco
Kuiper, Vincent P
Prins, Corine
Janse, Jacqueline J
Lamers, Olivia A C
Koopman, Jan Pieter R
Kruithof, Annelieke C
Kamerling, Ingrid M C
Dijkland, Romy C
de Kroon, Alicia C
Azimi, Shohreh
Feltkamp, Mariet C W
Kuijer, Marjan
Jochems, Simon P
Heemskerk, Mirjam H M
Rosendaal, Frits R
Roestenberg, Meta
Visser, Leo G
Roukens, Anna H E
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial.Published in
NPJ Vaccines 2024;9(1):1PMID
38167735ae974a485f413a2113503eed53cd6c53
10.1038/s41541-023-00785-w
Scopus Count
Collections
Related articles
- Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial.
- Authors: Tawinprai K, Siripongboonsitti T, Porntharukchareon T, Wittayasak K, Thonwirak N, Soonklang K, Sornsamdang G, Auewarakul C, Mahanonda N
- Issue date: 2022 Mar 15
- Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.
- Authors: Gao L, Li Y, He P, Chen Z, Yang H, Li F, Zhang S, Wang D, Wang G, Yang S, Gong L, Ding F, Ling M, Wang X, Ci L, Dai L, Gao GF, Huang T, Hu Z, Ying Z, Sun J, Zuo X
- Issue date: 2023 Apr
- Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
- Authors: Soonawala D, Verdijk P, Wijmenga-Monsuur AJ, Boog CJ, Koedam P, Visser LG, Rots NY
- Issue date: 2013 Aug 12
- Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine.
- Authors: Temtanakitpaisan Y, Saengnipanthkul S, Sarakosol N, Maskasame S, Mongkon S, Buranrat B, Thammawat S, Patamatamkul S, Nernsai P
- Issue date: 2022 Dec
- Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers.
- Authors: Prins MLM, Prins C, de Vries JJC, Visser LG, Roukens AHE
- Issue date: 2023 Sep